Cary Street Partners Investment Advisory’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-500
Closed -$48.6K 1056
2023
Q3
$48.6K Hold
500
﹤0.01% 876
2023
Q2
$54.2K Hold
500
﹤0.01% 798
2023
Q1
$53.8K Hold
500
﹤0.01% 729
2022
Q4
$54.4K Buy
+500
New +$52.4K ﹤0.01% 721
2020
Q4
Sell
-500
Closed -$47K 540
2020
Q3
$47K Buy
+500
New +$46.8K 0.01% 503

Other funds holding FXH

Cary Street Partners Investment Advisory's FXH Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q4 2023, closing a stake of 500 shares — an estimated $48.6K sold.

Cary Street Partners Investment Advisory first reported a position in FXH in Q3 2020 and held it in 5 quarters. The position peaked at $54.4K in Q4 2022. 262 funds tracked by Wall St. Rank hold FXH as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining First Trust Health Care AlphaDEX Fund position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 500 First Trust Health Care AlphaDEX Fund shares in Q4 2023, an estimated $48.6K.
  • Cary Street Partners Investment Advisory first reported a position in First Trust Health Care AlphaDEX Fund in Q3 2020 and held it in 5 quarters.
  • Cary Street Partners Investment Advisory's First Trust Health Care AlphaDEX Fund position peaked at $54.4K in Q4 2022.
  • 262 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.